A major element of our Corporate Responsibility approach and practices is our public policy advocacy work, and our outreach to stakeholders.
In this section, we describe how we inform and advocate for public policies that foster research into innovative medicines and improve access to medicines, vaccines and health care. Merck believes it is our responsibility to work with policymakers and other stakeholders to explain our views ethically and transparently, providing analyses of the issues at stake, and sharing information that can help clarify complex topics. While our positions support the sustainability of our business, we believe they also are beneficial to society as a whole.
In addition, we describe in this section our approach to engaging with our various stakeholders. We believe this is fundamental to our understanding of – and providing responses to — society’s expectations of our Company across many dimensions of our global activities. These areas include our products and their effectiveness and safety profiles, how we make those products available, employment and ethical business practices, and our societal contributions and impact more generally. Throughout our operations, from discovery and development to distribution, our engagement with stakeholders guides our business strategy and decisions. We believe it also enhances understanding of – and trust in – our business.
We recognize that our outreach activities can help address important issues, leveraging the expertise of all stakeholders to develop sustainable solutions to societal challenges such as disease, lack of education, environmental problems and corruption. Merck has pioneered far-reaching programs and partnerships, the results of which demonstrate that working together can achieve more than individual stakeholders alone – and can truly make a sustainable difference.
The content on this page was last modified on October 24, 2008.
Printer Friendly Page
